Leukemia Lymphocytic Chronic B-cell
📧 Sign up to get email alerts when something new happens for Leukemia Lymphocytic Chronic B-cell.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2020-06-24EMA Application withdrawn: Rituximab Mabion (rituximab) — Mabion Spolka Akcyjna
The EMA application for Rituximab Mabion (rituximab) by Mabion Spolka Akcyjna has been withdrawn.
-
EMA withdrawal · 2012-08-15EMA Withdrawn: MabCampath (alemtuzumab) — Genzyme Europe B.V.
EMA withdrew MabCampath (alemtuzumab) from the market.